Challenges & Successes in Moving Promising Preclinical Cannabinoid Drug Candidates to the Clinic

Time: 1:30 pm
day: Day One Track A - afternoon


  • Identify robust pre-clinical drug targets for cannabinoid drug development
  • Evaluate pre- and post-COVID cannabinoid drug development challenges: spotlight on systemic inflammatory disease
  • Examine future development of cannabinoid drug products for expanded disease indications